Indonesia commits to $34m investment in TB
This article was originally published in Clinica
The Indonesian government is to invest at least US$34m in TB care, under a debt-cancellation agreement with Australia. Honouring a commitment made in 2007, Australia will cancel a Aus$75m (US$68m) debt, on the basis that Indonesia will invest at least half of this amount in national TB programmes approved by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.